With plans for a major expansion of its site North Carolina, Fresenius Kabi's investments aimed mainly at the U.S. generics market now top $5 billion.

AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.

Here's your pharma manufacturing news of note.

AmerisourceBergen will extend its reach with an $815 million deal to buy independent drug distributor H. D. Smith.

With a U.S. saline shortage intensifying, the FDA is getting Baxter preferential treatment in having power restored to saline plants in Puerto Rico.

Here's your pharma manufacturing news of note.

B. Braun, one of three main saline suppliers, is closing a plant for maintenance, a move it acknowledges will make a bad supply situation worse.

Cardinal Health has agreed to sell its China business to Shanghai Pharma for $557 million in cash.

Merck and GSK are coping with hepatitis A vaccine shortages as the U.S. is experiencing deadly outbreaks.